Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.

Ekso Bionics Holdings, Inc.

Esper Bionics develops prostheses and prosthetic control technologies for people with limb differences as well as assistive devices and wearable sensors for paralyzed individuals. The company aims to create a bionic ecosystem of connected devices to enhance human capabilities.

Esper Bionics

German Bionic is a leading provider of robotic exoskeleton solutions designed to enhance human performance in industrial settings. The company's products aim to increase the safety and efficiency of workers by providing ergonomic support that reduces physical strain and the risk of injury.

Dirk Poeschl

Armin Schmidt

German Bionic

Ekso Bionics develops and manufactures exoskeleton technology to augment human capabilities. The company focuses on creating wearable robots that enhance mobility and strength for medical and industrial applications.

Ekso Bionics

EksoWorks

Since 2005, Ekso Bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company’s first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, Ekso Bionics is helping people rethink current physical limitations and achieve the remarkable.

Ekso Bionics is headquartered in San Rafael, California

International Offices:
Ekso Bionics Europe GmbH
Friesenweg 20 
Hamburg, 22763
Germany
Tel: +49 40 800 4049 20

Watch Will and Stephen in their Ekso Indego Personal exoskeletons as they effortlessly incorporate them into their daily routines. From walking in the park to doing household chores, Ekso Indego Personal brings newfound independence and ease to their lives.

Imagine the possibilities: standing tall, walking with confidence, and enjoying everyday activities with your loved ones. With Medicare coverage now available for those who qualify, accessing this revolutionary exoskeleton has never been more achievable.

Speak to your doctor to see if Ekso Indego Personal is right for you, and visit https://hubs.ly/Q02JgZ880 for more information and see if you qualify! 

#EksoIndegoPersonal #Mobility #Exoskeleton #Rehabilitation #DailyLife #Independence #MedicareCoverage #EksoBionics

We love seeing how different centers incorporate Ekso Indego into their therapy sessions! Check out NextStep Orlando Inc working hard with Casey who went to visit them all way from Next Step New Zealand. At Next Step Orlando, they use Ekso Indego to its full potential and really take advantage of its versatility, including its ability to enhance mobility, improve gait training, and support rehabilitation. It's inspiring to see how these advanced features make a real difference in their patients' lives! 

Learn more about Ekso Indego Therapy here: https://bit.ly/46xoTtG

#EksoNR #Rehabilitation #Mobility #NeurologicalRecovery #SpinalCordInjury

EksoEVO is perfect for anyone in a physically demanding job. It’s like having a supportive friend who’s got your back—literally. With EksoEVO, you’ll feel stronger and less fatigued, ready to take on your workday.

💪 Why You'll Love EksoEVO:

Feel Stronger: Handle repetitive tasks with ease.
Stay Safe: Protect yourself from workplace injuries.
Boost Productivity: Get more done without feeling exhausted.
Discover how EksoEVO can change the way you work. Your body will thank you!
https://hubs.la/Q02Jq56l0

#EksoEVO #WorkSmart #StayStrong #SafetyFirst #BoostYourDay #EksoBionics #WorkLife

Today, Ekso Bionics reported second quarter 2024 results, highlighted by record sales of $5.0 million, a total of 37 EksoHealth devices sold, gross margin of 53%, and initial Medicare claims for Ekso Indego Personal currently pending lump-sum reimbursement.

“We are pleased with our significant progress in the second quarter of 2024, highlighted by record sales and the announcement of CMS' national Medicare pricing determination for our Ekso Indego Personal device,” said Scott Davis, Chief Executive Officer of Ekso Bionics.

Read more about our second quarter results in our press release here: https://hubs.ly/Q02JhZ6N0

Imagine washing your face in the sink standing up again. Ekso Indego Personal integrates seamlessly into your daily life, offering those with spinal cord injuries the chance to experience everyday moments with newfound freedom and independence.

Medicare coverage may now be available for those who qualify. Speak to your doctor to see if Ekso Indego Personal is right for you, and visit our website to learn more: https://bit.ly/3AkS0nY

#EksoIndegoPersonal #DailyLiving #Independence #Exoskeleton #MedicareCoverage

We’re excited to announce that we will be at the National Veterans Wheelchair Games in New Orleans from July 25-30, 2024! 🎉
 
Come visit us at booth 312 and see Ekso Indego, our exoskeleton designed to enhance mobility and independence for individuals with spinal cord injuries. Whether you're a veteran or a supporter, we can't wait to show you how Ekso Indego is changing lives.
 
See you there!
 
#EksoBionics #EksoIndego #NationalVeteransWheelchairGames #Mobility #Independence #Veterans #Exoskeleton #NewOrleans2024 Paralyzed Veterans of America (PVA)

Metric
Company Name	Ekso Bionics Holdings, Inc.	Esper Bionics	German Bionic
Symbol	EKSO
MSH ID	COM:EKSOBIONICS	COM:ESPERBIONICS	COM:GERMANBIONIC
Market	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Technology
Industry	Medical - Instruments & Supplies	Medical Devices	Robotics and Exoskeleton Technology
Country	US	US	DE
Stage		Venture Round	Series A
Employee Count	70		77
Website	eksobionics.com	esperbionics.com	germanbionic.com
LinkedIn	eksobionics		germanbionic
Founders

Metric
Market Cap	19.73M
Enterprise Value
Monthly Web Traffic		2.67K	1.25K
Web Traffic Growth		0.57	0.24
Valuation
Raised Capital		5M	16.15M

Metric
Revenue	18.28M
Revenue (LTM)
Revenue (NTM)
Gross Profit	9.70M
EBITDA	-13.41M
Operating Income	-15.11M
Net Income	-15.20M
EPS	-1.10
Diluted EPS	-1.10
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.52
Operating Profit Margin	-0.66
EBITDA Margin	-0.73
Net Profit Margin	-0.68
Return on Equity	-0.90
Return on Assets	-0.46
Return on Capital Employed	-0.62

COM:EKSOBIONICS

Ekso Bionics

Last Close

0.72

22/11 21:00

Market Cap

19.73M

Beta: -

Volume Today

130.67K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-2.21
P/B Ratio	2.00
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.50
EV Multiple	-1.50

Metric
Days Sales Outstanding	126.22
Days Payables Outstanding	106.25
Days Inventory Outstanding	209.80
Operating Cycle	338.60
Cash Conversion Cycle	250.35
Asset Turnover	0.67

Metric
Operating Cash Flow	-12.05M
Free Cash Flow	-12.21M
Cash Flow to Debt	-1.26
Operating Cash Flow/Sales	-0.46
Free Cash Flow Yield	-0.37

Metric
Cash & Equivalents	8.64M
Accounts Receivable	-1.21M
Inventory	5.05M
Goodwill	431K
Debt to Capitalization	0.36
Debt to Assets	0.24
Current Ratio	2.85
Quick Ratio	2.11

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.16
R&D to Revenue	0.27
SG&A to Revenue	0.67